Fezakinumab

DB12344InvestigationalProtein Based Therapies

Fezakinumab has been used in trials studying the treatment of Atopic Dermatitis and Rheumatoid Arthritis.

Mechanism
Curator reviewed
Code names
ILV-094

Resolves to

Compound
UNII0S77U25XZ3CAS1007106-86-6
Targets
Q9GZX6IL22

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
381Drug interactionsStructured to mechanism, not free text
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Fezakinumab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In